Dr. Robin Rose

They looked at the spike protein and they looked at this enzyme called neutrophil elastase. So when you have SARS-CoV-2 and you have the virus, it activates the neutrophils, which is part of your white blood cells, right? Which fight off infection. They get activated. And then when the neutrophils get activated, they release this enzyme called neutrophil elastase.

They looked at the spike protein and they looked at this enzyme called neutrophil elastase. So when you have SARS-CoV-2 and you have the virus, it activates the neutrophils, which is part of your white blood cells, right? Which fight off infection. They get activated. And then when the neutrophils get activated, they release this enzyme called neutrophil elastase.

When neutrophil elastase, so it's an enzyme, right? So you know enzymes can cut things up. So when neutrophil elastase comes into contact with the spike protein and it cuts the protein at certain parts, you know, of that sequence.

When neutrophil elastase, so it's an enzyme, right? So you know enzymes can cut things up. So when neutrophil elastase comes into contact with the spike protein and it cuts the protein at certain parts, you know, of that sequence.

They identified seven different sequences or epitopes that get exposed when the spike protein comes in contact with the neutrophil elastase.

They identified seven different sequences or epitopes that get exposed when the spike protein comes in contact with the neutrophil elastase.

Those seven proteins are neurotoxic fibrils. They form neurotoxic fibrils on contact with the spike protein. So, and it's tau proteins, right? We know what tau, tau is Alzheimer's, right?

Those seven proteins are neurotoxic fibrils. They form neurotoxic fibrils on contact with the spike protein. So, and it's tau proteins, right? We know what tau, tau is Alzheimer's, right?

Alpha-synuclein, which is Parkinson's. CD, is it CD147? Or I forget, I think that's, or C, what's the other one? The one for ALS. There's beta amyloid, right? Beta amyloid, which we know is Alzheimer's too.

Alpha-synuclein, which is Parkinson's. CD, is it CD147? Or I forget, I think that's, or C, what's the other one? The one for ALS. There's beta amyloid, right? Beta amyloid, which we know is Alzheimer's too.

And they even identified one of, you know, and I can share that too with you so you can see the slide or you want to share the study with the audience. That's prionergic. meaning it could cause prion disease. Right. And so people, if people want to understand what that is, it's mad cow's disease.

And they even identified one of, you know, and I can share that too with you so you can see the slide or you want to share the study with the audience. That's prionergic. meaning it could cause prion disease. Right. And so people, if people want to understand what that is, it's mad cow's disease.

Right, right. And so that is why, because of this sort of soup of different, or in the soup, I think of it, like these different fibers that can form, you're almost seeing these people present, or we're seeing in the clinic, and when I talk to my beautiful colleagues out there that are really noticing this too,

Right, right. And so that is why, because of this sort of soup of different, or in the soup, I think of it, like these different fibers that can form, you're almost seeing these people present, or we're seeing in the clinic, and when I talk to my beautiful colleagues out there that are really noticing this too,

You're seeing like not even like straightforward ALS or straightforward Parkinson's or straight or it's like almost like a mishmash because you have a mishmash of these fibers being activated exposure. And so I was like, I know everyone's over it. I get it. I don't want you not to be over it.

You're seeing like not even like straightforward ALS or straightforward Parkinson's or straight or it's like almost like a mishmash because you have a mishmash of these fibers being activated exposure. And so I was like, I know everyone's over it. I get it. I don't want you not to be over it.

But, you know, even in the last year and a half alone, there's been three or four papers published by Nature's, Nature's Communication, just showing like a young person, like a young person with mild from just one exposure from a mild case or an asymptomatic case of COVID has brain changes, has gray matter changes, white matter changes.

But, you know, even in the last year and a half alone, there's been three or four papers published by Nature's, Nature's Communication, just showing like a young person, like a young person with mild from just one exposure from a mild case or an asymptomatic case of COVID has brain changes, has gray matter changes, white matter changes.

has decreased cerebral blood flow to their brain just after one exposure, right? So this is why now people are being exposed over and over again. And we already live in a toxic soup, right? So we already live in a toxic... And now you have this biotoxin on top of everything else that I think so many people are living right here and it just like pushed them over.

has decreased cerebral blood flow to their brain just after one exposure, right? So this is why now people are being exposed over and over again. And we already live in a toxic soup, right? So we already live in a toxic... And now you have this biotoxin on top of everything else that I think so many people are living right here and it just like pushed them over.